New York, NY -- (SBWIRE) -- 11/21/2012 -- Hemispherx BioPharma, Inc (NYSEAMEX:HEB) is currently trading at $0.730, 1.39% higher. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Will HEB Continue to Jump? Get Our Special Report To Get complete technical analysis on HEB go click my link
Vringo, Inc. (NYSEAMEX:VRNG) fell 2.22% to $3.53. Vringo, Inc. (Vringo) is a development-stage company. The Company is engaged in developing software for mobile phones. It provides a platform, which allows users to create, download and share mobile entertainment content in the form of video ringtones for mobile phones.
Get Free Trend Analysis on VRNG go click my link
New Gold Inc. (USA)(NYSEAMEX:NGD) is higher 2% to $10.19. New Gold Inc. is engaged in gold mining and related activities, including acquisition, exploration, extraction, processing and reclamation. Its operating assets consist of the Mesquite gold mine (Mesquite Mine) in the United States, the Cerro San Pedro gold-silver mine (Cerro San Pedro Mine) in Mexico, and the Peak gold-copper mines in Australia.
To Get complete technical analysis on NGD go click my link
Neostem Inc. (NYSEAMEX:NBS) among the losers and the stock fell 2.26% to $0.650. NeoStem, Inc. (NeoStem), is a international biopharmaceutical company. The Company operates in three segments: Cell Therapy-United States; Regenerative Medicine- China and Pharmaceutical Manufacturing-China.
Get Free Trend Analysis on NBS go click my link
Rexahn Pharmaceuticals, Inc. (NYSEAMEX:RNN) added 5.33% to $0.415. Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company’s pipeline features one drug candidate in Phase II clinical trials.
To Get complete technical analysis on RNN go click my link
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)